1:02 PM · 18 May 2020

Moderna’s stocks surge in pre-market on vaccine hopes. Dow futures up 500 points

Moderna’s (MRNA.US)  announced that its experimental vaccine for coronavirus showed promise in early trials. Biotech company announced that it's  early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants.  Vaccine also kept the virus that causes Covid-19 from replicating in the lungs of mice. Moderna has developed the first experimental coronavirus medicine, but an approved treatment is more than a year away.
Moderna’s (MRNA.US) stock rocketed over 28% in pre market trading. Source: xStation5
S&P500 (US500) -  Futures contracts tied to the major U.S. stock indexes rose sharply Monday, as news from a Moderna trial stoked optimism about a potential coronavirus vaccine. Source: xStation5
24 July 2026, 6:55 PM

Daily Summary: Equities Diverge as Tech Lags, Europe Rallies on Earnings & PMIs (24.07.2026)

24 July 2026, 5:43 PM

Three markets to watch next week (24.07.2026)

24 July 2026, 3:22 PM

US OPEN: Nasdaq hits 1-month low! Geopolitics bring AI trade down!

24 July 2026, 12:37 PM

Market Wrap: European Stocks Are Trying to Rebound as the Week Comes to an End💡

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits